Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Large Bore Catheter Facilitates Stroke Revascularization

By HospiMedica International staff writers
Posted on 08 Aug 2016
A novel reperfusion catheter leverages advanced tracking technology to deliver maximum aspiration power for extracting thrombii.

The ACE 68 Reperfusion Catheter is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease--within the internal carotid, middle cerebral – M1 and M2 segments, basilar, and vertebral arteries—and within eight hours of symptom onset. More...
The ACE 68 features a unique coil winding geometry along 16 transitions for optimal force transmission and kink resistance, a reinforced stainless steel coil construction to optimize pushability, and nitinol coil reinforcement for supple navigation.

The design creates an optimal profile to ensure easy tracking through tortuosity that is typical in acute ischemic stroke patients. The ACE 68 is intended for use with the Penumbra System, which offers a complete line of reperfusion catheters sized optimally for large vessel occlusions, and the aspiration power of the Penumbra Pump MAX to extract occluding clots en masse. The ACE 68 Reperfusion Catheter and the Penumbra System are products of Penumbra (Alameda, CA, USA), and have been approved by the U.S. Food and Drug Administration (FDA).

“With the ACE68 Reperfusion Catheter, I can easily deliver full aspiration power to the occlusion,” said assistant professor of neurology, neurosurgery, and radiology Johanna Fifi, MD, of Mount Sinai Hospital (New York, NY, USA). “The ACE68’s large lumen increases the likelihood of capturing the clot fully within the catheter or the canister, potentially reducing the number of passes to achieve complete revascularization and minimize embolization to new territory.”

“The tracking technology of the ACE68 Reperfusion Catheter is the most advanced. In my clinical experience with the ACE68, I saw the device easily navigate difficult tortuosity that would have challenged other devices,” said Blaise Baxter, MD, chief of radiology at Erlanger Hospital (Chattanooga, TN, USA). “ACE68’s tracking performance, combined with a large aspiration lumen to enable efficient clot removal, make ACE68 the most compelling frontline device in stroke intervention.”

Related Links:
Penumbra



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.